Journal article icon

Journal article

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

Abstract:

BACKGROUND: Highly active antiretroviral therapy (HAART) was introduced in 1997. We aimed to assess the continuing effect of this treatment on survival and progression to AIDS after HIV-1 seroconversion. METHODS: We used Cox models to estimate the effect of calendar year on time to AIDS and death in 22 cohorts of people from Europe, Australia, and Canada who had seroconverted. Retrospective and prospective data were used. We compared the effects of age at seroconversion, exposure category, s...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Expand authors...
Journal:
Lancet
Volume:
362
Issue:
9392
Pages:
1267-1274
Publication date:
2003-10-05
DOI:
EISSN:
1474-547X
ISSN:
0140-6736
URN:
uuid:afe62b19-816b-442a-aa49-856fc1b7a4e8
Source identifiers:
422662
Local pid:
pubs:422662

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP